Six medical journals rejected a key paper on COVID-19 vaccines and heart inflammation, a condition the vaccines cause, according to documents reviewed by The Epoch Times.
The U.S. Centers for Disease Control and Prevention (CDC)’s journal, Morbidity and Mortality Weekly Report (MMWR), was one of them.
CDC officials falsely told the paper’s authors that the paper did not add anything to a previously published CDC report, which estimated more COVID-19 hospitalizations would be prevented than cases of heart inflammation, or myocarditis, caused.
“I ran this by the MMWR lead editorial staff members; they felt that while the report was interesting, they did not feel that there was anything that was not already relayed,” Dr. Jacqueline Gindler, one of the officials, said in an Aug. 10, 2021, email.
The CDC a month earlier in a non-peer-reviewed paper estimated that among males aged 12 to 17, one million second Pfizer doses would cause up to 69 myocarditis cases but prevent some 5,700 COVID-19 cases and 215 COVID-19 hospitalizations.
The new paper clarified the risk-benefit calculus by separating children without serious underlying conditions such as obesity from children with one or more of the problems. It broke down the age group into two parts, 12- to 15 and 16- to 17. And it subtracted incidental hospitalizations, or hospitalizations where people test positive for COVID-19 but are actually being treated for other conditions.
The researchers estimated, using similar methods as the CDC, that one million doses would cause more cardiac adverse events in healthy boys than COVID-19 hospitalizations prevented. Among boys aged 12 to 15 without comorbidities, they calculated up to 6.1 times more adverse events among the vaccinated.
Both the CDC and the new paper utilized reports to the Vaccine Adverse Event Reporting System (VAERS), which the CDC co-manages.
Dr. Tracy Beth Hoeg, one of the paper’s co-authors, said that the CDC’s position that the paper did not add anything “was laughable.”
“What we added was stratification for non high-risk vs high-risk children, which was new,” Dr. Hoeg told The Epoch Times in an email. “We also reported a higher rate in 12-17 year olds than CDC had been reporting in males after dose two. Finally we removed incidental COVID-19 hospitalizations, when estimating potential vaccine benefits, which CDC had not been doing up to that point.”
Benjamin Hayes, a CDC spokesman who answered a query sent to Dr. Gindler, told The Epoch Times in an email that MMWR had to be “highly selective” due to receiving many submissions during the pandemic.
You must be logged in to post a comment.